Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Travoprost - Ocular Therapeutix

Next Previous
Drug Profile

Travoprost - Ocular Therapeutix

Alternative Names: Intracanalicular travoprost insert; OTX TIC; OTX-TP; OTX-TP1; OTX-TP2; OTX-TPa; OTX-TPb; PAXTRAVA; Sustained release travoprost; Travoprost implant; Travoprost insert; Travoprost intracameral implant; Travoprost ophthalmic insert

Latest Information Update: 09 Apr 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ocular Therapeutix
  • Class Antiglaucomas; Eye disorder therapies; Prostaglandins; Small molecules
  • Mechanism of Action Prostaglandin F2 alpha agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Ocular hypertension

Highest Development Phases

  • Phase III Ocular hypertension; Open-angle glaucoma
  • Phase II Glaucoma

Most Recent Events

  • 06 Apr 2024 Ocular Therapeutix plans End-of-phase II meeting with the US FDA to discuss plans for phase III trials in Open angle glaucoma and Ocular hypertension
  • 06 Apr 2024 Efficacy and adverse events data from a phase II trial in Glaucoma and Ocular hypertension released by Ocular Therapeutix
  • 06 Apr 2024 Ocular Therapeutix plans phase III trials in Open angle glaucoma and Ocular hypertension (Ophthalmic)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top